Circulating leukocytes that express selectin ligands such as the carbohydrate epitope sialyl Lewis X (sLeX) may interact with endothelial selectins, resulting in transmigration of the leukocyte across the endothelial wall to adjacent tissue. Due to the potential of selectin-ligand interactions as targets in viral pathogenesis, we aimed at determining whether herpes simplex virus type 1 (HSV1) is able to induce the appearance of sLeX at the surface of infected leukocytes. We found that HSV1 infection of a T-cell line resulted in transcriptional activation of human fucosyltransferase genes FUT3, FUT6 and FUT7, the two latter genes encoding the fucosyltransferases rate limiting for sLeX synthesis. Flow cytometry and confocal microscopy demonstrated that HSV1 infection resulted in a 2-fold rise in the proportion of sLeX-positive cells. Increased levels of FUT3, FUT6 and FUT7 RNA were detected already at 3 h post infection, and treatment with cycloheximide, a translation inhibitor, blocked a HSV1-induced increase in the expression of FUT3, FUT6 and FUT7 RNA, suggesting involvement of viral or cellular proteins. Studies with infectious viral mutants indicated that the viral immediate early (α) protein ICP0 is essential for the initiation of FUT7 though not for FUT3 or FUT6 transcription. In CD3+ cells, derived from peripheral blood mononuclear cells, HSV1 infection induced expression of FUT3, FUT5 and FUT6, whereas FUT7 was not altered. The mean sLeX fluorescence intensity of CD3+ cells was significantly higher in HSV1-infected CD3+ cells. This suggests that infected leukocytes during HSV1 viremia may express selectin ligands with possible but as yet unproven roles in viral pathogenesis.
Introduction
The normal interactions between endothelial selectins and their ligands are an important target in the pathogenesis of several types of tumors, including virus-induced neoplasia (Kannagi et al. 2004 (Kannagi et al. , 2011 Barthel et al. 2009; Sperandio et al. 2009 ). The natural function of the binding of endothelial selectins and their ligands at the leukocyte surface is to initiate the process by which various leukocytes leave the circulation via diapedesis through the endothelial wall for accessing different types of peripheral tissue (Sperandio et al. 2009 ). Selectin ligands are glycoproteins carrying carbohydrate epitopes, sialyl Lewis X (sLeX; Figure 1 ) or derivatives thereof, which are exposed at the surface of leukocytes predestined to routine homing to lymph nodes (Sperandio 2006) or to the sites of inflammation (Sperandio et al. 2009 ). Often formation of selectin ligands is suppressed and only switched on during priming of circulating leukocytes for diapedesis to inflammatory foci by transcriptional activation of a fucosyltransferase gene, whose product catalyzes the addition of a fucose in the sLeX-characteristic α(1-3) linkage, the last and rate-limiting step in sLeX synthesis (Barthel et al. 2009; Sperandio et al. 2009 ). By disingenuous activation of sLeX surface expression, circulating metastatic tumor cells recruit endothelial selectins as an efficient tool for adhesion to the endothelial wall and subsequent access to peripheral tissue without any need of inflammatory activation of the endothelial or tumor cells (Barthel et al. 2009 ). This principle has been delineated in detail for adult T-cell leukemia, an aggressive malignancy of T-helper cells, caused by human T-cell leukemia virus type 1 (HTLV-1; Kannagi 2001; Hiraiwa et al. 2003) . One of the clinical features of this disorder is skin infiltration of circulating leukemic cells, a process that is dependent on a viral protein activating the rate-limiting step for sLeX synthesis (Kannagi 2001) .
HTLV-1 induction of sLeX expression is carried out by viral control of a host gene critical for sLeX synthesis. In normal and in neoplastic cells synthesis of the direct sLeX precursor is carried out by a number of sequentially acting glycosyltransferases, most of which are constitutively expressed (Hiraiwa et al. 2003; Sperandio 2006; Sperandio et al. 2009 ). The fucosyltransferases capable of catalyzing the last step in sLeX synthesis, addition of a fucose in the sLeX-characteristic α(1-3) linkage (Figure 1 ), belong to a family of fucosyltransferases (Fuc-TIII, Fuc-TV, Fuc-TVI and Fuc-TVII), whose members are encoded by the human genes FUT3, FUT5, FUT6 and FUT7 (de Vries et al. 1997, 2001 ; Kimura et al. 1997) . These fucosyltransferases all have different kinetic properties and are differentially expressed in a tissue-dependent manner. Thus, Fuc-TVII is mainly expressed in leukocytes and constitutes the only fucosyltransferase with a strict product specificity for sLeX (de Vries et al. 1997 (de Vries et al. , 2001 ; Kimura et al. 1997) . In contrast, Fuc-TIII, Fuc-TV and Fuc-TVI are promiscuous, less efficient in sLeX formation and may participate in the formation of other sLeX-related glycoepitopes, such as LeY and sLeA ( Figure 1 ; Lofling and Holgersson, 2009) . In most types of cells, transcription of these FUT genes is suppressed and only induced upon specific activation of the cell, e.g. for diapedesis (Barthel et al. 2009; Sperandio et al. 2009 ). HTLV-1 bypasses the negative control of FUT7 transcription in transformed cells via the viral transactivator protein "tax", a process that initiates sLeX synthesis and primes the leukemic cells for skin colonization (Kannagi 2001; Hiraiwa et al. 2003) .
The involvement of virus-induced sLeX in tumor spread raises the question whether virus-induced selectin ligands may be of relevance also in the pathogenesis of non-tumor viruses. Herpesviruses are of particular interest in this context because they cause life-long persistent infections with occasional episodes of more active replication (White et al. 2012) . Circulating leukocytes play important roles in the pathogenesis of human Herpesviruses such as cytomegalovirus (CMV), Epstein-Barr virus (EBV; Paya et al. 1988; Kullberg-Lindh et al. 2008 ) and varicella-zoster virus (VZV; Ku et al. 2005) , and there is also evidence that virus-infected T-cells are involved in the viremia of herpes simplex virus types 1 and 2 (Gosselin et al. 1992; Aubert et al. 2009 ). HSV1 infects T-cells both by cell-free virus and by cell-to-cell spread via an intricate intercellular network designated the virological synapse (Gosselin et al. 1992; Aubert et al. 2009 ). However, at present, it is not known whether Herpesviruses induce sLeX expression in infected leukocytes and, consequently not, whether the selectin-ligand interaction is a target in pathogenesis. Our previous observation that several Herpesviruses, including HSV1, are able to induce sLeX in virus-infected human lung fibroblasts (HEL), by activating FUT3, FUT5 and FUT6 (Nyström et al. 2007 , therefore raised the question whether HSV1 infection also results in sLeX expression in leukocytes. Here, we demonstrate that HSV1 infection of T-cells is associated with sLeX expression in connection with virus-induced activation of preferentially FUT3 and FUT6 transcription in all types of T-cells tested, which is at variance with the situation in HTLV1-transformed T-cells, where FUT7 activation is the major cause of sLeX expression (Kannagi 2001; Hiraiwa et al. 2003) .
Results

HSV1-infected H9 cells as a model for viral-host interactions
H9 cells were considered as an experimental model for studies on herpesvirus influence on sLeX expression, because of previously reported low or even absent spontaneous expression of Lewis X and related antigens in these cells (Schulze-Forster and Maurer, 1997) . However, since HSV1 infection of most human cells of the T lineage is less efficient when compared with fully permissive cell types, e.g. epithelial cells (Aubert et al. 2009 ), it was necessary to confirm to assess the permissiveness of H9 cells for HSV1 infection, including the capacity to (a) carry out the transcription of viral early and late genes, (b) carry out viral genome replication and (c) produce infectious viral progeny.
First, we assayed the time kinetics of transcription of one immediate early (α) HSV1 gene, RL2, encoding the viral Fig. 1 . Structure representations of sLeX, sLeA and LeY. The glycoepitopes sLeX, sialyl Lewis A (sLeA) and Lewis Y (LeY) are assembled through the actions of several glycosyltransferases, each with a defined capacity to add a specific monosaccharide to a particular oligosaccharide acceptor via a specific glycosidic linkage. Gene identities of three families of isoenzymes (one sialyltransferase family and two fucosyltransferase families) of relevance for sLeX, sLeA and LeY synthesis are indicated. The glycosidic linkages to the fucose and galactose units are indicated.
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protein ICP0, and one late (γ) viral gene, UL27, encoding glycoprotein gB-1 (Figure 2A ). Total RNA was purified from infected cells at the time intervals indicated and assayed for RL2 or UL27 RNA. High levels of RL2 RNA was found already at the first time point at 1-hour post infection (h p.i.), which is in agreement with results for HSV1-infected HEL cells ). IL27 RNA was found somewhat later, at 3 h p.i., in HSV1-infected cells, suggesting an early onset of transcription in H9 cells also of traditionally late HSV1 genes. Thus, H9 cells were able to execute the HSV1 transcriptional program, including transcription of immediately early (α) and late (γ) viral genes.
Thereafter, we determined the levels of HSV1 DNA in the infected H9 cells, using a real-time PCR (qPCR) designed to quantify genomic HSV1 DNA (Namvar et al. 2005; Kullberg-Lindh et al. 2008 ; Figure 2B , upper panel). The HSV1 DNA synthesis inhibitor acyclovir (ACV) was used to differentiate between viral DNA from the initially added HSV1 particles and newly produced viral DNA (Norden et al. 2010) . The level of viral DNA was raised by approximately two log units, detectable at 12 h p.i., in the absence of ACV, whereas ACV treatment resulted in a drop in the DNA levels. These results indicated that progeny viral DNA was produced in HSV1-infected H9 cells. Most of the newly produced HSV1 DNA remained in the intracellular fraction of the infected H9 cells, but a small fraction corresponding to about 6% (12 h p.i.) and 12% (24 h p.i.), respectively, of the total HSV1 DNA was shed into the extracellular fraction ( Figure 2B , lower panel).
Finally, we examined whether infected H9 cells were able to produce infectious progeny virus by measuring the concentration of HSV1 over time in terms of plaque-forming units (PFUs) in the overlay medium ( Figure 2C ). There was an almost two log drop in the virus titer expressed as PFU/mL in the sample drawn after 5 h p.i., compared with the initial sample of washed H9 cells taken immediately after infection. This drop in PFU titer normally occurs because of cellular uptake of HSV1 particles added to the cells (Svennerholm et al. 1982) . However, at 12 h p.i., the titer (PFU) of HSV1 was increased by almost two log units to a plateau that continued at least to 24-h post-infection. The titer of progeny HSV1 produced here is 2-3 orders of magnitude lower than in traditionally HSV1-permissive cells (Roizman and Spear, 1968) . A control experiment, in which viral multiplication was blocked by ACV treatment, confirmed that the increasing levels of infectious HSV1 in the absence of ACV from 5 h p. i. indeed reflected the production of progeny virus as determined by the plaque assay. These results demonstrated the ability of H9 cells to carry out the complete HSV1 replicative cycle including the production of infectious progeny virus and, hence, confirmed the potential of HSV1-infected H9 cells as a model for the studies planned.
Expression of sLeX in HSV1-infected H9 cells Using the H9 model, we sought to demonstrate whether HSV1 induced an enhanced expression of sLeX, using the sLeX-specific CSLEX-1 antibody, in the infected H9 cells. HSV1-infected H9 cells were harvested for total RNA at the time intervals indicated and RNA levels were analyzed by RT-qPCR. The RNA levels for all genes were standardized compared with the reference gene 18S to avoid a bias due to viral infection and are therefore comparable with respect to the arbitrary units used . (B; upper panel) HSV1-infected H9, mock-treated or ACV-treated cells were harvested and extracted for DNA, followed by the determination of the HSV1 DNA load by qPCR. (Lower panel) In a separate experiment, the growth medium and the cellular fraction of HSV1-infected H9 cells were harvested at different time points, extracted for DNA, and assayed for progeny viral DNA by qPCR. (C) HSV1-infected cells in the presence or absence of ACV were harvested at the time intervals indicated, and the virus titre was determined by plaque assay in GMK cells.
Flow cytometry analysis demonstrated that HSV1 infection of H9 cells was associated with increased surface expression of sLeX in H9 cells ( Figure 3A) . A majority of the H9 cells in the infected culture expressed markers for productive HSV1 infection. About 45% of the HSV1-infected H9 cells also expressed sLeX, when compared with about 15% of the mock-infected H9 cells. Similar results were obtained with the alternative sLeX antibody, clone KM93 (data not shown). No evidence was found for HSV1-induced expression of the sLeX-related structures (Figure 1 ) sLeA or LeY in H9 cells ( Figure 3A , lower panels). The intracellular distribution of sLeX in HSV1-infected H9 cells was examined by immunofluorescence ( Figure 3B ). The mock-infected cells, negative for HSV1, showed a low grade reactivity toward sLeX, mostly as a few stray cytoplasmic dots. In contrast, the HSV1-infected cells stained positive for viral antigens, and a fraction of these cells were positive for sLeX with a bright, distinct fluorescence, which was surface associated or associated with cytoplasmic granulae, presumably Golgi vesicles.
HSV1-induced transcriptional activation of FUT genes in H9 cells
The fucosyltransferase encoded by the human FUT7 constitutes, in many situations, the rate-limiting factor for sLeX synthesis in leukocytes (Kannagi et al. 2011 ). However, since HSV1 induction of sLeX in HEL cells is dependent on transcription of one or more of the related FUT3, FUT5 and FUT6 rather than FUT7, we followed the transcription rates in HSV1-infected H9 cells of several relevant host FUT genes, using reverse transcriptase real-time PCR (RT-qPCR). As controls, we also analyzed the transcription of the host gene ST3Gal III, encoding a constitutively expressed sialyltransferase engaged in sLeX or sLeA synthesis (Figure 1 ), and C2GnT, encoding a glycosyltransferase of importance for the expression of sLeX in glycoprotein mucin domains (Lofling and Holgersson, 2009; Figure 4) . The calculation of comparable RNA levels was performed with the method by Nyström et al. (2004) designed to correct for viral interference with normally constant transcription rates of host house-keeping genes. The RNA levels for all genes analyzed at any time points are therefore comparable with respect to the arbitrary units used (Nyström et al. 2007 Nordén et al. 2009 ). The FUT7 transcription rate was enhanced by almost two log units, already at 3 h p.i., which is opposite to the absence of FUT7 transcription in HSV1-infected HEL cells ). Similar to the previously reported situation for HEL cells ), FUT3 and FUT6 expression were increased in HSV1-infected H9 cells also by two log units, respectively, but reaching maximal levels later than FUT7 RNA (5 h p.i. vs. 3 h p.i.) The FUT5 gene expression remained high but unaltered during early HSV1 infection of the H9 cells, when compared with a previously reported strong increase in FUT5 transcription in HSV1-infected HEL cells ). The other FUT genes investigated, except for FUT1 remained essentially unaltered during 
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infection. In conclusion, HSV1 infection of H9 cells resulted in the transcriptional activation of FUT7 and also of FUT3 and FUT6 normally activated in other cell types than leukocytes.
We found that two non-FUT glycosyltransferases relevant for sLex synthesis were only marginally decreased following HSV1 infection: C2GnT, whose gene product catalyzes the formation of one O-linked glycan core structure (Core 2) that may be elongated to larger structures, including sLex, and ST3Gal III encoding one of the sialyltransferase isoenzymes that creates the direct sLex precursor (Figure 1 ), i.e. the substrate for Fuc-TVII. Of other FUT genes, whose gene products are not involved in sLeX synthesis, we found that the transcription rate of FUT1, whose gene product competes with that of ST3Gal III resulting in the formation of LeY in the place of sLeX (Figure 1) , was increased by approximately one log unit (Figure 4 ). However, analysis by flow cytometry gave no evidence for increased expression of LeY after HSV1 infection ( Figure 3A) . The level of FUT2, determining the histo-blood group ABH secretor status of an individual, was not altered by HSV1 infection.
FUT genes and sLeX expression in HSV1-infected CD3+ cells from blood donors Next, we sought to determine how HSV1 infection affected its natural leukocyte target, CD3+ T-cells, including CD4+ and CD8+ T-cells (Aubert et al. 2009) , with respect to sLeX expression and transcription of relevant FUT genes. Peripheral blood mononuclear cells (PBMCs) from healthy blood donors were infected with HSV1. These cells are not immediately susceptible to synchronous infection by cell-free HSV1 particles and, therefore, we applied the infection procedure suggested by Aubert et al. (2009) , including Phaseolus vulgaris phytohemagglutinin (PHA) stimulation of the PBMC to mitosis, and subsequent HSV1 infection of the resulting cell population by co-cultivation with a monolayer of HSV1-infected HEL cells. The CD3+ T-cell population was isolated, and subjected to FUT RNA analysis (15 h. p.i.), and assayed for sLeX expression by flow cytometry. We found that FUT3 and FUT6 RNA levels were increased by almost three orders of magnitude ( Figure 5A ). FUT1 and FUT5 transcription was also increased by HSV-1 infection, but in contrast to the H9 cells, the FUT7 RNA level was not further elevated by HSV1 infection. The level of RL2 RNA, encoding a viral immediate early (α) protein, was almost four orders of magnitude higher than the RNA level of UL27, encoding a late viral protein, indicating a suboptimal activation of HSV1 late (γ) genes. This may explain the relatively low virus replication rate in CD3+ cells observed by others (Aubert et al. 2009 ).
In the flow cytometry experiments, the non-viable cells were excluded from further analysis, and the living CD3+ populations were analyzed with respect to sLeX and HSV1 expression, focussing on two aspects. First, we assayed (a) the proportion of the CD3+ cells in which the infectious cycle was driven sufficiently long to express HSV1-specific surface glycoproteins and (b) to what extent these HSV1-positive cells expressed sLeX. Thus, the majority (69%) of the viable CD3+ PBMC stained positive for the HSV1 surface marker ( Figure 5B ) and that approximately half (46%) of these HSV1-positive cells also expressed sLeX. The background of sLeX-positive cells in mock-infected cells was higher for CD3+ T-cells compared with H9 cells. The sLeX expression during the experimental conditions in CD3+ PBMC was not caused by the PHA treatment since similar proportions of PHA-treated and untreated CD3+ PBMC expressed sLeX (Supplementary data, Figure S1 ).
Secondly, we determined whether the HSV1 infection itself had any effect on the level of sLeX expressed in individual cells. We found that the sLeX mean fluorescence intensity Fig. 4 . RNA levels of host genes, relevant for sLeX and related structures, in HSV1-infected H9 cells. Mock-or HSV1-infected H9 cells were harvested for total RNA at the time intervals indicated and RNA levels were analyzed by RT-qPCR. The RNA levels for all genes were standardized when compared with the reference gene 18S to avoid a bias due to viral infection and are therefore comparable with respect to the arbitrary units used . RNA from HSV1-infected (filled squares) and mock-infected (open circles) cells are depicted.
(MFI) was 796 for mock-infected cells versus 1392 for HSV1-infected cells (P < 0.01) as determined in six independent experiments ( Figure 5C ), suggesting that expression of HSV1 genes was of relevance for increased levels of sLeX in the infected cells. In conclusion, the PBMC-derived CD3+ cells were susceptible to HSV1 infection, and expression of viral genes was associated with elevated sLeX expression in the infected cells.
Protein synthesis involved in viral induction of FUT genes in H9 cells
Owing to the strict role of a viral RNA rather than a viral protein in virus-induced transcription FUT3, FUT5 and FUT6 in HSV1-infected HEL cells ), we investigated the effects of cycloheximide (CHX), a translation inhibitor, on the transcription of selected FUT genes in HSV1-infected T-cells, using the H9 model system (Figure 6 ). Pertinent for the interpretation of the results is that CHX treatment increased the background levels of FUT3, FUT6 and FUT7 transcription also in the absence of viral infection, , where CD3+ cells were isolated and harvested for total RNA 15 h p.i. and were analyzed by RT-qPCR. The RNA levels for all genes were standardized compared with the reference gene 18S to avoid a bias due to viral infection and are therefore comparable with respect to the arbitrary units used . Expression of FUT genes in HSV1-infected CD3 + cells and the viral genes RL2 and UL27 are depicted. (B) Mock-or HSV1-infected PBMC analyzed at 15 h p.i. using a polyclonal rabbit anti-serum to HSV1 glycoproteins or the sLeX CSLEX antibody as indicated in the figure. The CD3+ population was identified and the living fraction of cells was further analyzed for HSV1 and sLeX expression. (C) The sLeX intensity (MFI) in mock-and HSV1-infected CD3+ T-cells in six independent experiments (**P < 0.01). 
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probably reflecting CHX-dependent elimination of a protein repressor as described for HEL cells ). There was no difference in the FUT3, FUT6 and FU7 RNA levels of CHX-treated, HSV1-infected cells, respectively, compared with corresponding levels observed in CHX-treated, mock-infected cells. In the absence of CHX treatment, HSV1 infection induced as expected similar increased levels of FUT3, FUT6 and FUT7 RNA as observed in Figure 4 . Altogether, the results indicated that maximal levels of HSV1-induced FUT3, FUT6 and FUT7 transcription in H9 cells were dependent on the synthesis of early viral proteins and/or maintained host protein synthesis after infection. CHX treatment did not alter the transcription rate of the constitutively expressed cellular ST3Gal III gene or the viral immediate early (α) gene, RL2, encoding the viral regulatory factor ICP0. However, transcription of the late viral UL27 gene was completely inhibited by CHX (Figure 6 , lower panels). This confirmed that CHX did not have any general effects on the transcription of cellular genes nor on the transcription of RL2 during the early phase of infection, while late viral genes as expected were found to be dependent on the synthesis of early viral proteins.
Involvement of viral immediate early protein ICP0 in HSV1-induced FUT gene transcription and sLeX expression
The CHX sensitivity of HSV1-induced FUT3, FUT6 and FUT7 transcription in infected H9 cells suggested a role for one or more virus-encoded proteins in the transcriptional activation of these genes. The HSV1 gene, RL2, encoding the immediate early (α) viral protein ICP0 was chosen as a primary viral candidate gene because RL2 is one of the first HSV1 genes to be transcribed, and its gene product, ICP0, is involved in the regulation of subsequently expressed viral genes and in viral influence on host gene transcription in the infected cell (Everett 2000; Hagglund and Roizman, 2004; Roizman et al. 2005) . The ICP0 studies were performed with an HSV1 deletion mutant, dl1403, with large deletions in both copies of the RL2 gene (Stow and Stow, 1986) . Total RNA was purified from infected cells at the time interval indicated and assayed for host FUT3, FUT6, FUT7 and ST3Gal III RNA. Besides RL2, we also analyzed the RNA levels of another immediately early (α) HSV1 gene, RS1, encoding a viral protein designated ICP4, the late (γ) viral gene UL27 (encoding glycoprotein gB-1). The assay for measuring RL2 was performed using two separate RT-qPCR methods: one detecting RNA from an intact region of RL2 present in and also transcribed in cells infected with dl1403 and the other only detecting full length transcripts and hence not RNA from the truncated RL2 of the dl1403 mutant ).
Again, HSV1 wild-type virus infection resulted in a two log increase in the transcription rate of FUT7 when compared with uninfected cells ( Figure 7A ). In contrast, the FUT7 RNA level in the cells infected with dl1403 was comparable with that of uninfected cells, i.e. two logs lower than in cells infected with wild-type virus. The FUT3 and FUT6 RNA levels were 1.5 and 2 orders of magnitude, respectively, higher in wild-type virus-infected cells, but in contrast to FUT7, the FUT3 and FUT6 RNA levels were increased also in cells infected with dl1403, albeit at a lower level. The The same cells as in (A) assayed for RL2 RNA, using primer systems detecting either a RL2 gene target present only in the wild-type virus (RL2 complete) or detecting a RL2 target present also in the remaining part of the truncated RL2 in the ΔRL2 mutant virus (RL2 truncated). The cells were also assayed for RS1, an immediate early HSV1 gene, and UL27 RNA. (C) HSV1 WT, ΔRL2 and mock-infected H9 cells were analyzed for sLeX expression using flow cytometry. The values indicate the percentage of positive cells (black line) compared with the isotype control (gray area). Statistical calculations are described in Material and methods (*P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001; see Material and methods).
RNA levels of ST3Gal III were similar for uninfected H9 cells and cells infected with wild type or dl1403, confirming no ICP0 effect on the host constitutively expressed genes. As expected, only the cells infected with wild-type virus transcribed full length RL2 RNA, whereas mutant and wild-type virus displayed almost the identical levels of truncated RL2 RNA, demonstrating equal transcription levels of the RL2 gene irrespective if the cells were infected with wild-type or mutant virus. The transcription of rate of the RS1 gene was equally high in H9 cells infected with dl1403 and wild-type virus ( Figure 7B ), indicating that synthesis of ICP4, another HSV1 immediate early (α) regulatory viral protein, was not transcriptionally regulated by ICP0. In contrast, the transcription rate of the late (γ) gene UL27 was one log unit lower in cells infected with dl1403 than in cells infected with wildtype virus, underscoring the significance of ICP0 in promoting the transcription of subsequently expressed HSV1 genes ( Figure 7B ). The results indicated that ICP0 is necessary for the HSV1 induction of FUT7, either as a direct activator of host cell functions or indirectly via its influence on one or more of the many viral genes that are expressed downstream of the immediate early (α) viral genes. Virus-induced transcription of FUT3 and FUT6, on the other hand, takes place at only marginally decreased levels in the absence of functional ICP0.
One intriguing question is whether the increased levels of FUT3 and FUT6 transcription in H9 cells infected with the RS2-deficient mutant virus are sufficient to induce sLeX in spite of the scarce expression of FUT7 induced by the mutant virus. We found that the number of sLeX-positive cells were similar for cells infected with wild-type virus and RL2-deficient virus, respectively, when compared with mockinfected cells ( Figure 7C ). This result suggested that the level of α(1-3)fucosyltransferase activity achieved in cells infected with the RL2-deficient virus via FUT6 activation was sufficient for efficient sLeX expression despite the lack of a increased level of FUT7 transcription.
Discussion
Virus-infected leukocytes play important roles in the pathogenesis of traditionally blood-borne Herpesviruses, particularly in immunocompromised patients. Thus, large numbers of latently or actively infected leukocytes circulate in CMV-or EBV-infected individuals with the suppressed immune system, often for long periods of time (Kullberg-Lindh et al. 2008) . Increased numbers of sLeX-expressing leukocytes that were demonstrated in CMV-induced organ rejection in transplant patients (Lautenschlager et al. 1996) may suggest a role for interactions between selectins and their ligands in CMV infection of immunocompromised patients, a notion supported also by the experimental data (Cebulla et al. 2000) . There is also evidence that virus-infected leukocytes are of significance in the pathogenesis of neurotropic viruses such as HSV1 (Gosselin et al. 1992; Jerome 2008; Aubert et al. 2009 ) and VZV (reviewed in Ku et al. 2005) . Still, the possible roles of selectin ligands in these processes are only scarcely known, but data presented here demonstrate that HSV1 indeed possesses useful tools for inducing the surface expression of selectin-ligands such as sLeX in virus-infected leukocytes harboring an actively replicating viral genome.
The HSV1-dependent effects on sLeX expression in H9 and in PBMC-derived CD3+ T-cells included an increased number of sLeX-positive cells, but also an increased intensity of the sLeX fluorescence signal. The finding that a large proportion of the HSV1-infected CD3+ T-cells and H9 cells expressed a viral glycoprotein of the late (γ) transcriptional class of viral genes, demonstrating that these cells were able to execute the entire viral transcriptional program, a notion also supported by transcriptional analysis of representative viral genes. As was previously demonstrated for HSV1-infected HEL cells Nyström et al. 2009 ), only a subset, corresponding to 36-46% of the HSV1-positive H9 or CD3+ T-cells were induced to express sLeX in spite of the high levels of FUT RNA detected in the infected cells. It is important to note that the FUT RNA levels represent the average of all cells in the culture and cannot be excluded that the viral induction of host genes was asymmetrical, resulting in some cells with extremely high FUT transcription and others in which the relevant FUT gene products were suboptimal for sLeX formation. A similar phenomenon was described for the normal oral mucosa in which adjacent cells may have different glycoepitope expression patterns owing to small differences in the differentiation status of these cells (Mandel 1992) .
One important finding here was that HSV1-augmented expression of sLeX in CD3+ PBMC-derived T-cells was dependent on virus-induced transcription of FUT5 and FUT6. The involvement of FUT3 is less likely as its gene product prefers type 1 structures (Figure 1 ) rather than type 2 structures, which is a prerequisite for sLeX formation (de Vries et al. 2001) . The contribution of FucT-VII in sLeX augmentation is also less likely, because in spite of the augmented expression of sLeX in HSV1-infected CD3+ T-cells, no difference in the transcription of FUT7 between HSV1-infected and mock-infected cells could be detected. The situation in HSV1-infected H9 cells was different inasmuch as FUT5 transcription was not up-regulated, whereas a prominent increase in the FUT7 transcription was observed. Thus, HSV1 may activate the transcription of several FUT genes, all involved in the synthesis of sLeX in a host cell-dependent manner. There may be several explanations behind the absence of the related glycoepitopes, such as LeY or sLeA, in H9 cells and PBMC-derived CD3+ T-cells, despite increased transcription of FUT1 and FUT3. It is, however, noteworthy that the relative balance between competing virus-activated glycosyltransferases decides the ability of CMV to induce exclusive expression of either sLeX or LeY in infected HEL cells (Nyström et al. 2007 ).
The use of H9 cells that were synchronously infected by HSV1 offered an ideal model for studies dissecting the first few hours of interactions between viral factors and host gene products that result in sLeX synthesis. The mechanism by which transcription of FUT7 is induced in HSV1-infected H9 cells appeared different from the HSV1 mode of the activation of FUT3 and FUT6 transcription. Thus, synthesis of the immediate early (α) protein ICP0 was found here to be a Selectin ligands in herpesvirus-infected T-cells prerequisite for the activation of FUT7 transcription. Although ICP0 is capable of affecting host gene transcription (Roizman et al. 2005) , there is a possibility that the ICP0 effect is indirect, i.e. by the control of later transcriptional classes of HSV1 genes, whose products may interact with host transcriptional factors. On the other hand, the HSV1-induced levels of FUT3 and FUT6 RNA were only marginally lower in the H9 cells infected with dl1403 when compared with wild-type virus, contrasting to the strict dependence on ICP0 for increased FUT7 transcription, demonstrating a role for ICP0-independent viral factors. Indeed, our observation that the RS1 gene, encoding the viral immediate early (α) regulatory factor ICP4, was transcribed at the same rate in H9 cells infected with dl1403 when compared with wild-type virus, confirmed that there exists HSV1 genes that are transcribed in an ICP0-independent manner in HSV1-infected cells of the T-cell lineage.
A subset of CD3+ T-cells that circulate in HSV1-infected patients during viremic spread contain actively replicating HSV1 genomes, expressing ICP0, ICP4 and other viral factors engaged in transcriptional regulation (Gosselin et al. 1992; Aubert et al. 2009 ). One intriguing question pertains to how many of these circulating virus-positive cells that also express increased levels of sLeX as a consequence of viral activation of appropriate FUT genes in analogy with experimental situation for HSV1 infection of PBMC-derived CD3+ T-cells. Any viral strategy for the colonization of secondary tissue via possible interactions between circulating HSV1-infected T-cells and endothelial selectins may be facilitated by the existence of sLeX-expressing HSV1-infected CD3+ cells and promoted by the relatively long life span of HSV1-infected T-cells, i.e. at least 1 week (Gosselin et al. 1992 ).
Persistent infections with traditionally blood-borne Herpesviruses such as CMV and EBV in the growing group of patients with severe immunosuppression and carrying high levels of leukocyte-associated virus during several months are a great medical problem (Kullberg-Lindh et al. 2008) . Although CMV and VZV, like HSV1, are able to induce sLeX in virus-infected HEL cells (Nyström et al. 2007) , it is at present not known whether this is true for CMV-infected or EBV-transformed leukocytes. However, the mechanisms by which different viruses, including the transforming retrovirus, HTLV-1 (Kannagi 2001; Hiraiwa et al. 2003) , and a traditionally cytolytic herpesvirus, HSV1 ( present study), are able to express sLeX are diverse. This opens the possibility that also regulatory proteins of other Herpesviruses are able to activate host genes necessary for sLeX expression in virus-infected leukocytes. The immediate early regulatory system is conserved among Herpesviruses, and VZV as well as CMV encode proteins with similar regulatory functions as HSV1 ICP0 and ICP4 (Kenyon et al. 2001; Lee et al. 2004; Everett et al. 2010) . Furthermore, CMV and EBV encode additional early acting factors with an even more profound capacity to interact with host cell functions (White et al. 2012) . Several agents targeting the interactions between selectins and their ligands are in clinical trials for the treatment of metastatic tumors (Bedard and Kaila, 2010) , and these substances may offer alternative treatment principles, should selectin-ligand interactions be involved also in herpesvirus pathogenesis?
Materials and methods
Viruses and cells
The wild-type HSV1 virus Syn17+ (Marsden et al. 1976 ) was used throughout the study, and the virus titers were determined by plaque titration on Green monkey kidney (GMK) cells as previously described (Mardberg et al. 2004 ). The mutant virus mutant dl1403, defective in ICP0 through deletion of the majority of both copies of the gene RL2 (Stow and Stow, 1986) , was propagated as previously described ).
The H9 T-lymphocyte cell line (ATCC HTB-176), a clonal derivate of Hut78, was used in the study, and the cells were cultivated in RPMI 1640 supplemented with fetal calf serum (FCS) and 1% penicillin-streptomycin as previously described (Hemming et al. 1996) . PBMCs were isolated by FicollHypaque density gradient centrifugation (GE Healthcare, Chalfont, St. Giles, UK) from blood obtained from healthy blood donors. The PBMCs were maintained in RPMI 1640 supplemented with 10% heat-inactivated FCS and 1% penicillin-streptomycin (RPMI-FCS). The isolated PBMCs were incubated in RPMI-FCS supplemented with 2.5 μg/mL PHA (Sigma Aldrich, St Louis, MO) for 3-4 days to induce mitosis (Aubert et al. 2009 ). Diploid human embryonic lung fibroblasts (HEL) at the low passage level were cultivated in Eagle's MEM with 10% FCS, 1% penicillin-streptomycin and 1% L-glutamine (Nyström et al. 2007 ).
HSV1 infection in cell culture
For cell-free infection, HSV1 at a multiplicity of infection (MOI) of 10 plaque-forming units (PFUs) per cell were added to H9 cells in 6-well culture plates (10 6 cells/well). The viral particles were allowed to attach to the cells for 1 h at 37°C and 5% CO 2 before the inoculum was removed by centrifugation at 300 × g for 7 min, and new growth medium was added. After different intervals of infection, each well was harvested and extracted for RNA or prepared for flow cytometry or confocal microscopy.
PBMC cultures were infected using cell-to-cell infection as described by Aubert et al. (2009) . Briefly, HEL cells in 6-well plates were infected with HSV1 at a MOI of 10 PFU/cells according to previously published methods (Nyström et al. 2007) , and the infected HEL cells were incubated 8-12 h at 37°C and 5% CO 2 . Thereafter, the growth medium was removed and the medium with PHA-activated PBMCs was added to a final concentration of 4 × 10 6 cells/well. The cells were incubated 10-15 h at 37°C and 5% CO 2 . At the end of the incubation, PBMCs were removed from the HEL cells and washed in PBS and stored at 4°C until analyzed by flow cytometry.
Isolation of CD3+ T-cells CD3+ cells were isolated from HSV1 and mock-infected PBMC with anti-human CD3 magnetic particles (BD Pharmingen, San Diego, CA) according to the manufacturer's instructions. Briefly, PBMC were washed in 1× BD IMag ( phosphate-buffered saline with 0.5% BSA and 2 mM EDTA), and 10 7 cells were incubated with 50 µL magnetic particles for 30 min. CD3+ cells were bound to a magnet and the CD3− fraction was washed away with 1× BD IMag.
RNA extraction
The procedure for RNA extraction has been described previously Nyström et al. 2009 ). Prior to RNA extraction, the cells were washed with PBS and lysed with 300 µL 2× nucleic acid purification lysis solution (Applied Biosystems, Foster City, CA) mixed with 300 µL PBS. The 6100 Nucleic Acid Prepstation (Applied Biosystems) was used for the purification of total RNA according to the manufacturer's instructions including DNase treatment for total RNA extraction. The RNeasy kit (Qiagen, Hilden, Germany) was used for RNA isolation from CD3+ PBMC according to the manufacturer's instructions. The final RNA concentration was determined by measuring the absorbance values at 260/280 nm using an Ultrospec 2100 pro UV/ visible spectrophotometer. Additional DNase treatment, when necessary, was performed with Turbo DNAfree (Ambion, Austin, TX) according to the manufacturer's instructions.
Real-time PCR RT-qPCR was performed as previously described according to the manufacturer's instructions regarding Taqman™ chemistry ). Relative concentrations of transcripts from different glycosyltransferase genes and HSV early or late genes were determined using the ΔCT method, as optimized to compensate for herpesvirus-induced effects on the transcription of β-actin and other house-keeping genes ). Primers and probes for RL2 complete, RL2 truncated, RS1, UL27, FUT1, FUT2, FUT3, FUT4, FUT5, FUT6, FUT7, FUT9, β-actin and ST3Gal III were previously described (Nyström et al. 2007 Nordén et al. 2009 Nordén et al. , 2010 . The following primers and probes were selected for the human glucosaminyl (N-acetyl) transferase 1, core 2 (GCNT1; Accession NM_001097636) mRNA using the Primer Express™ software: forward primer: CGCTT CCTGTTTTAGTAATGTCTTTG; reverse primer: CCGGCTC CACGATGCA; probe: FAM-CAGCCGATTGGAGAGTGT GGTT-TAMRA.
The experiments were performed at least three times on separate occasions. One typical infection is displayed for all q-RT PCR graphs, and the error bars are based on triplicates from this one infection occasion and represent the standard deviation.
Monitoring of HSV1 infection of H9 cells
The production of progeny HSV1 and viral DNA was assayed by plaque titration and qPCR, respectively. Briefly, H9 cells in 24-well culture plates (500 000 cells/well) were incubated with HSV1 at a MOI of 10 PFU/cells. Virus was allowed to attach to the cells for 1 h at 37°C and 5% CO 2 before the inoculum was removed. Cells were collected at different time intervals and subjected to plaque titration on GMK cells as previously described (Mardberg et al. 2004 ). HSV1 DNA production was assayed both in the overlay medium and in the infected cell sap. At the time points indicated the overlay medium and the cell sap was harvested, and the harvested cell fraction was lysed (Svennerholm et al. 1982) , and medium as well as the cell extract were extracted for DNA, and finally subjected to qPCR for the quantitation of HSV1 DNA using the system by Namvar et al. (2005) adapted for the quantitation of herpesvirus DNA (Kullberg-Lindh et al. 2008) .
Flow cytometry analysis HSV1 and mock-infected H9 cells or PBMCs were washed in PBS and incubated with primary IgM antibodies toward sLeX (clone CSLEX-1; BD Pharmingen, San Diego, CA and clone KM93; Chemicon International, Temecula, CA) at a concentration of 1-2 and 0.1 µg/mL, respectively, IgM antibodies toward sLeA (clone 121SLE; Abcam, Cambridge, UK) at 1 µg/mL and LeY (clone F3; Abcam) at a dilution of 1:1000 and an isotype control (clone 2-25LE; Abcam) at a concentration of 3.3 µg/mL, at 4°C for 1 h. The cells were washed in 10 mL PBS and the secondary antibody, goat anti-mouse IgM conjugated to Alexafluor 647 (Invitrogen, Eugene, OR) at a concentration of 0.67 µg/mL, was applied and incubated at 4°C in the dark for 30 min. A third incubation, at 4°C in the dark for 30 min, with anti-HSV-FITC (DAKO, Glostrup, Denmark) diluted 1:500, anti CD3-PE-Cy7 (BD Pharmingen, San Diego, CA) diluted 1:50 and LIVE/DEAD violet stain (Invitrogen) diluted 1:3000 was performed after additional wash in 10 mL PBS.
Finally, the cells were washed in 10 mL PBS and incubated with 0.5% paraformaldehyde at 4°C for 60 min. The cells were washed in PBS and kept at 4°C until analysis with flow cytometry using a FACSAria™ (BD Biosciences). The analysis of the flow cytometry standard files was performed using the FlowJo 7.6.5 software (Treestar, Ashland, OR). The gating of the cells in respect of sLeX was based on the isotype control values. The strategy for isolating the living HSV1 and sLeX-expressing H9 cells is outlined in Supplementary material (Supplementary data, Figure S1 ), and the gating strategy for isolating the living CD3+ cells that expressed both HSV1 and sLeX antigens is also outlined in Supplementary material (Supplementary data, Figure S2 ).
Immunofluorescence
The procedures for immunofluorescence with slight modifications have been published previously (Nyström et al. 2007 . Briefly, the cells were infected with HSV1 at a MOI of 10 PFU/cells and incubated at 37°C as well as 5% CO 2 for 15 h and then transferred to Teflon-coated object slides. Subsequently, the slides were dried and fixated in ice cold acetone for 5 min. The slides were allowed to dry and stored at −80°C. Immunofluorescence was performed on the slides with human sera containing antibodies directed against HSV1 diluted 1:600, and IgM antibodies against sLeX (clone KM93; Chemicon International) at a concentration of 5 µg/ mL. The primary antibodies were incubated overnight at 4°C. Secondary TRITC-conjugated anti-human antibody (Jackson ImmunoResearch, West Grove, PA) and FITC-conjugated antimouse antibody (Dako, Glostrup, Denmark) were used at dilutions of 1:400 and 1:100, respectively, and incubated for 1 h at 37°C. All dilutions of antibodies were performed in 3% BSA in PBS. Prolong Gold Anti-fade Kit with 4′,6-diamidino-2-phenylindole (DAPI; Invitrogen Molecular Probes, Eugene, OR) was used as mounting fluid on the slides. The slides were analyzed in a Zeiss LSM 510 Meta Selectin ligands in herpesvirus-infected T-cells confocal microscope (Carl Zeiss, Oberkochen, Germany) using a Plan-Apochromat 63× objective in oil immersion.
Statistical analysis
The MFI comparison in Figure 5 was performed using an unpaired Student t-test, and the indicated P-value is two sided. Statistical significance was calculated in Figures 6 and 7 using either one-way analysis of variances followed by the Bonferroni multiple comparison test or unpaired Student's t-test. Significance is depicted as not significant (ns), *P < 0.05, **P < 0.01, ***P < 0.005 and ****P < 0.001. All statistical calculations are done from two to four separate infections. The error bars for all RT-qPCR graphs are triplicates from one infection, where a typical infection is displayed.
Supplementary data
Supplementary data for this article is available online at http:// glycob.oxfordjournals.org/.
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